arrow
M

Martin Kerschensteiner

Ludwig-Maximilians-Universitat Munchen
H指数:53
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibodies against MLC1 found in patients with NMOSD-like disease mediate astrocytopathy in rodent models

NMOSD样疾病患者中发现的抗MLC1抗体介导啮齿动物模型中的星形胶质细胞病变

2026-08-260
PRE
Feasibility of short imaging protocols for [18F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophy

[18F]氟去甲氧基苯丙胺-D2 PET在自身免疫性脑炎和多系统萎缩中短成像协议的可行性

2026-05-280
OAAI
Prognostic value of evoked potentials for disease progression in early multiple sclerosis and clinically isolated syndrome in the prospective multicentre ProVal-MS study

早期多发性硬化及临床孤立综合征中诱发电位对疾病进展的预测价值:前瞻性多中心ProVal-MS研究

2026-04-140
PRE
Hyperreflective Foci in the Inner Nuclear Layer: Proof-of-Concept for an Optical Coherence Tomography Derived Microglia-Related Marker in Multiple Sclerosis

内核层高反射焦点:多发性硬化中基于光学相干断层扫描的微胶质细胞相关标记的概念验证

2026-04-070
OAAI
In vivo CRISPR screen reveals regulation of macrophage states in neuroinflammation

体内CRISPR筛选揭示了神经炎症中巨噬细胞状态的调控

2025-12-040
OAAI
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis

SV2A-PET成像揭示了多发性硬化中的皮层突触丢失

2025-10-011
PRE
The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis

免疫蛋白酶体扰乱神经元代谢并驱动多发性硬化中的神经退行性变

Cell
IF42.5
2025-09-300
OAAI
[18F]fluorodeprenyl-D2 PET can detect and monitor astrogliosis in anti-LGI1-IgG autoimmune encephalitis

[18F]fluorodeprenyl-D2 PET可以检测并监测抗LGI1-IgG自身免疫性脑炎中的星形胶质细胞增生

2025-09-260
OAAI
Twin study identifies early immunological and metabolic dysregulation of CD8+ T cells in multiple sclerosis

双胞胎研究确定多发性硬化症中CD8 T细胞的早期免疫和代谢失调

2024-09-270
PRE
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis
2024-06-191
OAAI
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories

通过高维血液特征识别的多发性硬化症内表型与不同的疾病轨迹相关

2024-03-274
PRE
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study
2024-03-072
OAAI
Identification of multiple sclerosis endophenotypes by high dimensional blood signatures associated with distinct disease trajectories
2023-04-250
PRE
[18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data
2023-03-1110
OAAI